After signing a drug pricing deal with the White House, J&J will now offer some of its branded medicines at discounted rates ...
No matter where you are in your investment journey, dividends can become the backbone of your income. Dividend stocks are an ideal way to generate money from your investment; they can help cover ...
Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, designed for sustained efficacy, improved tolerability, and ...
The Dow" is short for the Dow Jones Industrial Average. It's often used as a proxy for the entire U.S. stock market.
A three-judge panel of the Boston-based 1st U.S. Circuit Court of Appeals rejected a request by President Donald Trump's ...
New data show that psychiatric advanced practice practitioners provide guideline-concordant schizophrenia care that is ...
A federal appeals court has blocked a Trump administration initiative that would have required hospitals serving low-income Americans to pay full prices upfront for certain high-cost prescription ...
Fintel on MSN
UBS upgrades Bristol-Myers Squibb (BMY)
Fintel reports that on January 7, 2026, UBS upgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Neutral to Buy.
Gilead Sciences promoted Keeley Wettan to EVP, general counsel, legal and compliance. She will join the senior leadership ...
As of Wednesday, January 07, CytomX Therapeutics, Inc.’s CTMX share price has surged by 6.40%, which has investors questioning if this is right time to sell.
The big news in the drug sector is the emergence of GLP-1 weight loss drugs, but dig deeper, and you'll find relatively cheap ...
Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results